Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring the impact of gut microbiota and diet on breast cancer risk and progression
Nancy M. Y. Teng, Christopher A. Price, Alastair M. McKee, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 3, pp. 494-504
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Gut microbiota and risk of five common cancers: A univariable and multivariable Mendelian randomization study
Zixin Wei, Biying Yang, Tiantian Tang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 9, pp. 10393-10405
Open Access | Times Cited: 57
Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth
Alastair M. McKee, Benjamin Kirkup, Matthew Madgwick, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103012-103012
Open Access | Times Cited: 59
The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota
Man Wang, Fei Yu, Yuan Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 4, pp. 1451-1475
Open Access | Times Cited: 48
The early-life gut microbiome and vaccine efficacy
Anne Jordan, Simon R. Carding, Lindsay J. Hall
The Lancet Microbe (2022) Vol. 3, Iss. 10, pp. e787-e794
Open Access | Times Cited: 39
Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer via regulating Hedgehog signaling pathway
Xinyue Hu, Xuan Xu, Xiangdi Zeng, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Beyond Proteins—Edible Insects as a Source of Dietary Fiber
Carolyne Kipkoech
Polysaccharides (2023) Vol. 4, Iss. 2, pp. 116-128
Open Access | Times Cited: 26
Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment
Huixin Wu, Sebanti Ganguly, Trygve O. Tollefsbol
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1727-1727
Open Access | Times Cited: 35
Emerging Relationship between the Gut Microbiome and Prostate Cancer
Makoto Matsushita, Kazutoshi Fujita, Koji Hatano, et al.
The World Journal of Men s Health (2023) Vol. 41, Iss. 4, pp. 759-759
Open Access | Times Cited: 20
Mendelian randomization analysis revealed a gut microbiota–mammary axis in breast cancer
Shuwan Zhang, Wenchuan Zhang, Haiyue Ren, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 17
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Rama Rao Malla, Rakshmitha Marni, Seema Kumari, et al.
Clinical Breast Cancer (2021) Vol. 22, Iss. 3, pp. 200-211
Closed Access | Times Cited: 38
Impact of Gut Microbiota on the Association between Diet and Depressive Symptoms in Breast Cancer
Gusonghan Maitiniyazi, Xiaoyun Cao, Yue Chen, et al.
Nutrients (2022) Vol. 14, Iss. 6, pp. 1186-1186
Open Access | Times Cited: 22
Prebiotics: Ignored player in the fight against cancer
Parichita Mishra, Vidhi Manish Badiyani, Sakshi Jain, et al.
Cancer Reports (2023) Vol. 6, Iss. 11
Open Access | Times Cited: 11
The immunoregulatory role of gut microbiota in the incidence, progression, and therapy of breast cancer
Kaiyang Xue, Jiawei Li, Ruijie Huang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
FASN inhibition shows the potential for enhancing radiotherapy outcomes by targeting glycolysis, AKT, and ERK pathways in breast cancer
Ching-I Chen, Deng-Yu Kuo, Hui-Yen Chuang
International Journal of Radiation Biology (2025), pp. 1-12
Open Access
Epigenetic Landscapes of Aging in Breast Cancer Survivors: Unraveling the Impact of Therapeutic Interventions—A Scoping Review
Nikita Nikita, Zhengyang Sun, Swapnil Sharma, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 866-866
Open Access
The cancer microbiome
Huapeng Li, Anne A. Leaman, Qingfei Zheng
Advances in clinical chemistry (2025)
Closed Access
Breast cancer but not the menopausal status is associated with small changes of the gut microbiota
Natalia Żeber‐Lubecka, Maria Kulecka, Agnieszka Jagiełło-Gruszfeld, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Impact of intestinal dysbiosis on breast cancer metastasis and progression
Jin Zhang, Qiqi Xie, Xingfa Huo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study
Francesco Schettini, Alessandra Fontana, Federica Gattazzo, et al.
European Journal of Cancer (2023) Vol. 191, pp. 112948-112948
Open Access | Times Cited: 7
The crosstalk of the human microbiome in breast and colon cancer: A metabolomics analysis
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Pragya Bradu, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103757-103757
Closed Access | Times Cited: 11
A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: ß-Glucuronidase Enzyme Identified as Potential Therapeutic Target
M. Leonor Fernández‐Murga, F. Gil-Ortiz, Lucía Serrano-García, et al.
(2023)
Open Access | Times Cited: 5
Polyphenol-Enriched Blueberry Preparation Controls Breast Cancer Stem Cells by Targeting FOXO1 and miR-145
Jean‐François Mallet, Roghayeh Shahbazi, Nawal Alsadi, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4330-4330
Open Access | Times Cited: 12
A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target
M. Leonor Fernández‐Murga, F. Gil-Ortiz, Lucía Serrano-García, et al.
Pathogens (2023) Vol. 12, Iss. 9, pp. 1086-1086
Open Access | Times Cited: 4
Profiling the gut and oral microbiota of hormone-receptor positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulin
Stephen D. Robinson, Nancy M. Y. Teng, Andrea Malfettone, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top